跳至主要内容
临床试验/IRCT2015122125641N1
IRCT2015122125641N1已完成2 期

Effect of Cyanrol in treatment of Non-alcoholic fatty liver disease: a randomized double-blind clinical trial including plaebo

Vice chancellor for research of Baqiyatallah University of Medical Science0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 139 years(—)
性别
All

入选标准

  • patient has Fatty Liver; The history of allergic reaction to the drug combination is not relevant; Over 18 years old; The patient has informed consent to participate in the study; Exclusion criteria: The patient who stops the medication more than 1 week; The patient with the history of biliary disease; The patient with Fatty Liver, who also has Hyperlipidemia and receives statins; Patient with Fatty Liver, who also has another liver disease; Pregnancy and lactation; The patient who expresses uncontrolled adverse effects by this drug; Alcohol consumption and any addictive drugs..

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research of Baqiyatallah University of Medical Science

相似试验